AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors
Nanoscale. 2024 Feb 1;16(5):2347-2360. doi: 10.1039/d3nr04777f.
L.Carmès, G.Bort, F.Lux, et al.
Pharmaceuticals. 2024 Aug 5. doi: 10.3390/ph17081033.
B.Dhaini, P.Arnoux, J.Daouk, et al.